Literature DB >> 16415864

An essential role for DeltaFosB in the nucleus accumbens in morphine action.

Venetia Zachariou1, Carlos A Bolanos, Dana E Selley, David Theobald, Michael P Cassidy, Max B Kelz, Tamara Shaw-Lutchman, Olivier Berton, Laura J Sim-Selley, Ralph J Dileone, Arvind Kumar, Eric J Nestler.   

Abstract

The transcription factor DeltaFosB is induced in the nucleus accumbens (NAc) and dorsal striatum by the repeated administration of drugs of abuse. Here, we investigated the role of DeltaFosB in the NAc in behavioral responses to opiates. We achieved overexpression of DeltaFosB by using a bitransgenic mouse line that inducibly expresses the protein in the NAc and dorsal striatum and by using viral-mediated gene transfer to specifically express the protein in the NAc. DeltaFosB overexpression in the NAc increased the sensitivity of the mice to the rewarding effects of morphine and led to exacerbated physical dependence, but also reduced their sensitivity to the analgesic effects of morphine and led to faster development of analgesic tolerance. The opioid peptide dynorphin seemed to be one target through which DeltaFosB produced this behavioral phenotype. Together, these experiments demonstrated that DeltaFosB in the NAc, partly through the repression of dynorphin expression, mediates several major features of opiate addiction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415864     DOI: 10.1038/nn1636

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  120 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia.

Authors:  J Thomas Cunningham; W David Knight; Steven W Mifflin; Eric J Nestler
Journal:  Hypertension       Date:  2012-06-11       Impact factor: 10.190

3.  ΔFosB in the nucleus accumbens is critical for reinforcing effects of sexual reward.

Authors:  K K Pitchers; K S Frohmader; V Vialou; E Mouzon; E J Nestler; M N Lehman; L M Coolen
Journal:  Genes Brain Behav       Date:  2010-08-16       Impact factor: 3.449

4.  Reduced ΔFosB expression in the rat nucleus accumbens has causal role in the neuropathic pain phenotype.

Authors:  Sarah L Pollema-Mays; Maria Virginia Centeno; Zheng Chang; A Vania Apkarian; Marco Martina
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

Review 5.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

Review 6.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

7.  Effects of prolonged treatment with the opiate tramadol on prodynorphin gene expression in rat CNS.

Authors:  Sanzio Candeletti; Giuseppe Lopetuso; Rosalia Cannarsa; Chiara Cavina; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

8.  Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine.

Authors:  Ling-Yan Su; Rongcan Luo; Qianjin Liu; Jing-Ran Su; Lu-Xiu Yang; Yu-Qiang Ding; Lin Xu; Yong-Gang Yao
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

9.  ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.

Authors:  Matthew F Lazenka; Dana E Selley; Laura J Sim-Selley
Journal:  Neuropharmacology       Date:  2013-09-30       Impact factor: 5.250

10.  FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Authors:  Joseph R Patterson; Elizabeth J Kim; John L Goudreau; Keith J Lookingland
Journal:  Brain Res       Date:  2016-08-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.